Smoking and rheumatoid arthritis

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 22279-22295

  Chang, Kathleen ^a   Yang, So Min ^b   Kim, Seong Heon ^c   Han, Kyoung Hee ^d   Park, Se Jin ^e   Shin, Jae Il ^b  

^a MONASH UNIVERSITY   (Australia)

^b Yonsei University College of Medicine   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Jeju National University School of Medicine   (South Korea)

^e Ajou University School of Medicine   (South Korea)

Author keywords

Cyclic citrullinated peptide; Drug response; Rheumatoid arthritis; Smoking; Synovial fibroblasts

Indexed keywords

AUTOANTIBODY; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; NICOTINE; TUMOR NECROSIS FACTOR INHIBITOR;

APOPTOSIS; DISEASE PREDISPOSITION; DNA METHYLATION; DRUG RESPONSE; EXTRA ARTICULAR MANIFESTATION; FIBROBLAST; GENETIC EPIGENESIS; HEREDITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOBIOLOGY; INFLAMMATION; META ANALYSIS (TOPIC); OXIDATIVE STRESS; PHYSICAL DISEASE BY ANATOMICAL STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEROLOGY; SMOKING; SYNOVIOCYTE; TREATMENT RESPONSE; ADVERSE EFFECTS; ANIMAL; ARTHRITIS, RHEUMATOID; DRUG EFFECTS; IMMUNE SYSTEM; PATHOLOGY;

ANIMALIA;

ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE SUSCEPTIBILITY; FIBROBLASTS; HUMANS; IMMUNE SYSTEM; RISK FACTORS; SMOKING;

EID: 84919360132     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151222279     Document Type: Review

References (105)

1. Scott, D.L.; Wolfe, F.; Huizinga, T.W. Rheumatoid arthritis. Lancet 2010, 376, 1094–1108.
2. Cooles, F.A.; Isaacs, J.D. Pathophysiology of rheumatoid arthritis. Curr. Opin. Rheumatol. 2011, 23, 233–240.
3. Mongey, A.B.; Hess, E.V. Drug and environmental effects on the induction of autoimmunity. J. Lab. Clin. Med. 1993, 122, 652–657.
4. Sopori, M. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2002, 2, 372–377.
5. Harel-Meir, M.; Sherer, Y.; Shoenfeld, Y. Tobacco smoking and autoimmune rheumatic diseases. Nat. Clin. Pract. Rheumatol. 2007, 3, 707–715.
6. Onozaki, K. Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. Inflamm. Allergy Drug Targets 2009, 8, 364–368.
7. Ruiz-Esquide, V.; Sanmartí, R. Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatol. Clin. 2012, 8, 342–350.
8. Hoovestol, R.A.; Mikuls, T.R. Environmental exposures and rheumatoid arthritis risk. Curr. Rheumatol. Rep. 2011, 13, 431–439.
9. Vessey, M.P.; Villard-Mackintosh, L.; Yeates, D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 1987, 35, 457–464.
10. Heliövaara, M.; Aho, K.; Aromaa, A.; Knekt, P.; Reunanen, A. Smoking and risk of rheumatoid arthritis. J. Rheumatol. 1993, 20, 1830–1835.
11. Uhlig, T.; Hagen, K.B.; Kvien, T.K. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J. Rheumatol. 1999, 26, 47–54.
12. Karlson, E.W.; Lee, I.M.; Cook, N.R.; Manson, J.E.; Buring, J.E.; Hennekens, C.H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheumatol. 1999, 42, 910–917.
13. Criswell, L.A.; Merlino, L.A.; Cerhan, J.R.; Mikuls, T.R.; Mudano, A.S.; Burma, M.; Folsom, A.R.; Saag, K.G. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: Results from the Iowa Women’s Health Study. Am. J. Med. 2002, 112, 465–471.
14. Padyukov, L.; Silva, C.; Stolt, P.; Alfredsson, L.; Klareskog, L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheumatol. 2004, 50, 3085–3092.
15. Costenbader, K.H.; Feskanich, D.; Mandl, L.A.; Karlson, EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am. J. Med. 2006, 119, 503.e1–9.
16. Sugiyama, D.; Nishimura, K.; Tamaki, K.; Tsuji, G.; Nakazawa, T.; Morinobu, A.; Kumagai, S. Impact of smoking as a risk factor for developing rheumatoid arthritis: A meta-analysis of observational studies. Ann. Rheum. Dis. 2010, 69, 70–81.
17. Di Giuseppe, D.; Discacciati, A.; Orsini, N.; Wolk, A. Cigarette smoking and risk of rheumatoid arthritis: A dose-response meta-analysis. Arthritis Res. Ther. 2014, 16, R61.
18. Krishnan, E.; Sokka, T.; Hannonen, P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis. Res. Ther. 2003, 5, R158–R162.
19. Stolt P.; Bengtsson C.; Nordmark B.; Lindblad S.; Lundberg I.; Klareskog L.; Alfredsson L. EIRA study group: Quantification of the influence of cigarette smoking on rheumatoid arthritis: Results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 2003, 62, 835–841.
20. Pryor, WA.; Stone, K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N. Y. Acad. Sci. 1993, 686, 12–28.
21. Kalpakcioglu, B.; Senel, K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin. Rheumatol. 2007, 27, 141–145.
22. Barr, J.; Sharma, C.S.; Sarkar, S.; Wise, K.; Dong, L.; Periyakaruppan, A.; Ramesh, G.T. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol. Cell. Biochem. 2007, 297, 93–99.
23. Cheng, X.L.; Zhang, H.; Guo, D.; Qiao, Z.D. Upregulation of Fas and FasL expression in nicotine-induced apoptosis of endothelial cells. Methods Find. Exp. Clin. Pharmacol. 2010, 32, 13–18.
24. Bijl, M.; Horst, G.; Limburg, P.C.; Kallenberg C.G. Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes. Eur. J. Clin. Investig. 2001, 31, 550–553.
25. Imirzalioĝlu, P.; Uckan, S.; Alaaddinoĝlu, E.E.; Haberal, A.; Uckan, D. Cigarette smoking and apoptosis. J. Periodontol. 2005, 76, 737–739.
26. Peng, S.L. Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford) 2006, 45, 26–30.
27. Genestier, L.; Paillot, R.; Fournel, S.; Ferraro C.; Miossec P.; Revillard J.P. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Investig. 1998, 102, 322–328.
28. Mizushima, N.; Kohsaka, H.; Miyasaka, N. Ceramide, a mediator of interleukin 1, tumour necrosis factor α, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells. Ann. Rheum. Dis. 1998, 57, 495–499.
29. Holt, P.G.; Keast, D. Environmentally induced changes in immunological function: Acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol. Rev. 1977, 41, 205–216.
30. Reynolds, H.Y. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 1987, 135, 250–263.
31. Bracke, K.; Cataldo, D.; Maes, T.; Gueders, M.; Noël, A.; Foidart, J.M.; Brusselle, G.; Pauwels, R.A. Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice. Int. Arch. Allergy Immunol. 2005, 138, 169–179.
32. Liu, Y.; Aryee, M.J.; Padyukov, L.; Fallin, M.D.; Hesselberg, E.; Runarsson, A.; Reinius, L.; Acevedo, N.; Taub, M.; Ronninger, M. et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol. 2013, 31, 142–147.
33. Wang, H.; Yu, M.; Ochani, M.; Amella, C.A.; Tanovic, M.; Susarla, S.; Li, J.H.; Wang, H.; Yang, H.; Ulloa, L. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421, 384–388.
34. Raitio, A.; Tuomas, H.; Kokkonen, N. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers. Arch. Dermatol. Res. 2005, 297, 242–248.
35. Xue, M.; McKelvey, K.; Shen, K.; Minhas, N.; March, L.; Park, S.Y.; Jackson, C.J. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation. Rheumatology (Oxford) 2014, doi:10.1093/rheumatology/keu254.
36. Ferson, M.; Edwards, A.; Lind, A.; Milton, G.W.; Hersey, P. Low natural-killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int. J. Cancer 1979, 23, 603–609.
37. Shegarfi, H.; Naddafi, F.; Mirshafiey, A. Natural killer cells and their role in rheumatoid arthritis: Friend or foe? Sci. World J. 2012, doi:10.1100/2012/491974.
38. Kawada, T. Smoking-induced leukocytosis can persist after cessation of smoking. Arch. Med. Res. 2004, 35, 246–250.
39. Johnson, J.D.; Houchens, D.P.; Kluwe, W.M.; Craig, D.K.; Fisher, G.L. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: A review. Crit. Rev. Toxicol. 1990, 20, 369–395.
40. Cozen, W.; Diaz-Sanchez, D.; Gauderman, J.W. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J. Clin. Immunol. 2004, 24, 617–622.
41. Arnson, Y.; Shoenfeld, Y.; Amital, H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J. Autoimmun. 2010, 34, J258–265.
42. Yoshida, Y.; Tanaka, T. Interleukin 6 and rheumatoid arthritis. Biomed. Res. Int. 2014, doi:10.1155/2014/698313.
43. Klimiuk, P.A.; Fiedorczyk, M.; Sierakowski, S.; Chwiecko, J. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand. J. Rheumatol. 2007, 36, 345–350.
44. Klimiuk, P.A.; Sierakowski, S.; Latosiewicz, R.; Cylwik, J.P.; Cylwik, B.; Skowronski, J.; Chwiecko, J. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann. Rheum. Dis. 2002, 61, 804–809.
45. Gibbons, L.J.; Hyrich, K.L. Biologic therapy for rheumatoid arthritis: Clinical efficacy and predictors of response. BioDrugs 2009, 23, 111–124.
46. Benedetti, G.; Miossec, P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur. J. Immunol. 2014, 44, 339–347.
47. Harrison, O.J.; Foley, J.; Bolognese, B.J.; Long, E., III; Podolin, P.L.; Walsh, P.T. Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement. Immunol. Lett. 2008, 121, 13–21.
48. Wegner, N.; Lundberg, K.; Kinloch, A.; Fisher, B.; Malmström, V.; Feldmann, M.; Venables, P.J. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 2010, 233, 34–54.
49. Klareskog, L.; Stolt, P.; Lundberg, K.; Källberg, H.; Bengtsson, C.; Grunewald, J.; Rönnelid, J.; Harris, H.E.; Ulfgren, A.K.; Rantapää-Dahlqvist, S. et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheumatol. 2006, 54, 38–46.
50. Gregersen, P.K.; Silver, J.; Winchester, R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheumatol. 1987, 30, 1205–1213.
51. Mattey, D.L.; Dawes, P.T.; Clarke, S. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheumatol. 2002, 47, 403–407.
52. Viatte, S.; Plant, D.; Raychaudhuri, S. Genetics and epigenetics of rheumatoid arthritis. Nat. Rev. Rheumatol. 2013, 9, 141–153.
53. Zeilinger, S.; Kühnel, B.; Klopp, N.; Baurecht, H.; Kleinschmidt, A.; Gieger, C.; Weidinger, S.; Lattka, E.; Adamski, J.; Peters, A. et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 2013, 8, e63812.
54. Wu, S.; Luo, H.; Xiao, X.; Zhang, H.; Li, T.; Zuo, X. Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur. J. Pharmacol. 2014, 735, 97–104.
55. Van Maanen, M.A.; Lebre, M.C.; van der Poll, T.; LaRosa, G.J.; Elbaum, D.; Vervoordeldonk, M.J.; Tak, P.P. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheumatol. 2009, 60, 114–122.
56. Zhou, Y.; Zuo, X.; Li, Y.; Wang, Y.; Zhao, H.; Xiao, X. Nicotine inhibits tumor necrosis factor-α induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatol. Int. 2012, 32, 97–104.
57. Yu, H.; Yang, Y.H.; Rajaiah, R.; Moudgil, K.D. Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anti-cyclic citrullinated peptide antibodies. Arthritis Rheumatol. 2011, 63, 981–991.
58. Vesperini, V.; Lukas, C.; Fautrel, B.; Le Loet, X.; Rincheval, N.; Combe, B. Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: Results from a French multicenter cohort. Arthritis Care Res. (Hoboken) 2013, 65, 1899–1906.
59. Jiang, X.; Alfredsson, L.; Klareskog, L.; Bengtsson, C. Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) case-control study. Arthritis Care Res. (Hoboken). 2014, doi:10.1002/acr.22325.
60. MacGregor, A.J.; Snieder, H.; Rigby, A.S.; Koskenvuo, M.; Kaprio, J.; Aho, K.; Silman, A.J. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheumatol. 2000, 43, 30–37.
61. Bang, S.Y.; Lee, K.H.; Cho, S.K.; Lee, H.S.; Lee, K.W.; Bae, S.C. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheumatol. 2010, 62, 369–377.
62. Wagner, C.A.; Sokolove, J.; Lahey, L.J.; Bengtsson, C.; Saevarsdottir, S.; Alfredsson, L.; Delanoy, M.; Lindstrom, T.M.; Walker, R.P.; Bromberg, R. et al. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: Association with cigarette smoking and HLA-DRB1 “shared epitope” alleles. Ann. Rheum. Dis. 2014, doi:10.1136/annrheumdis-2013-203915.
63. Gregersen, P.K. Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond. Immunol. Rev. 2005, 204, 74–86.
64. Taylor, L.H.; Twigg, S.; Worthington, J.; Emery, P.; Morgan, A.W.; Wilson, A.G.; Teare, M.D. Metaanalysis of the association of smoking and PTPN22 R620W genotype on autoantibody status and radiological erosions in rheumatoid arthritis. J. Rheumatol. 2013, 40, 1048–1053.
65. Keenan, B.T.; Chibnik, L.B.; Cui, J.; Ding, B.; Padyukov, L.; Kallberg, H.; Bengtsson, C.; Klareskog, L.; Alfredsson, L.; Karlson, E.W. Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis. Arthritis Rheumatol. 2010, 62, 3196–3210.
66. Mikuls, T.R.; Levan, T.; Gould, K.A.; Yu, F.; Thiele, G.M.; Bynote, K.K.; Conn, D.; Jonas, B.L.; Callahan, L.F.; Smith, E. et al. Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans. Arthritis Rheumatol. 2012; 64, 655–664.
67. Kristiansen, M.; Frisch, M.; Madsen, H.O.; Garred, P.; Jacobsen, S. Smoking and polymorphisms of genes encoding mannose-binding lectin and surfactant protein-D in patients with rheumatoid arthritis. Rheumatol. Int. 2014, 34, 373–380.
68. Bartok, B.; Firestein, G.S. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol. Rev. 2010, 233, 233–255.
69. Huber, L.C; Distler, O.; Tarner, I.; Gay, R.E.; Gay, S.; Pap, T. Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45, 669–675.
70. Buchan, G.; Barrett, K.; Turner, M.; Chantry, D.; Maini, R.N.; Feldmann, M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: Prolonged production of IL-1 alpha. Clin. Exp. Immunol. 1988, 73, 449–455.
71. Shizu, M.; Itoh, Y.; Sunahara, R.; Chujo, S.; Hayashi, H.; Ide, Y.; Takii, T.; Koshiko, M.; Chung, S.W.; Hayakawa, K. et al. Cigarette smoke condensate upregulates the gene and protein expression of proinflammatory cytokines in human fibroblast-like synoviocyte line. J. Interferon Cytokine Res. 2008, 28, 509–521.
72. Adachi, M.; Okamoto, S.; Chujyo, S.; Arakawa, T.; Yokoyama, M.; Yamada, K.; Hayashi, A.; Akita, K.; Takeno, M.; Itoh, S. et al. Cigarette smoke condensate extracts induce IL-1-beta production from rheumatoid arthritis patient-derived synoviocytes, but not osteoarthritis patient-derived synoviocytes, through aryl hydrocarbon receptor-dependent NF-kappa-B activation and novel NF-kappa-B sites. J. Interferon Cytokine Res. 2013, 33, 297–307.
73. Hyrich, K.L.; Watson, K.D.; Silman, A.J.; Symmons, D.P. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2006, 45, 1558–1565.
74. Söderlin, M.K.; Petersson, I.F.; Geborek, P. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scand. J. Rheumatol. 2012, 41, 1–9.
75. Tamaki, A.; Hayashi, H.; Nakajima, H.; Takii, T.; Katagiri, D.; Miyazawa, K.; Hirose, K.; Onozaki, K. Polycyclic aromatic hydrocarbon increases mRNA level for interleukin 1 beta in human fibroblast-like synoviocyte line via aryl hydrocarbon receptor. Biol. Pharm. Bull. 2004, 27, 407–410.
76. Finkel, T.; Deng, C.X.; Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460, 587–591.
77. Niederer, F.; Ospelt, C.; Brentano, F.; Hottiger, M.O.; Gay, R.E.; Gay, S.; Detmar, M.; Kyburz, D. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann. Rheum. Dis. 2011, 70, 1866–1873.
78. Engler, A.; Niederer, F.; Klein, K.; Gay, R.E.; Kyburz, D.; Camici, G.G.; Gay, S.; Ospelt, C. SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts. J. Mol. Med. 2014, 92, 757–767.
79. Ling, S.; Cline, E.N.; Haug, T.S.; Fox, D.A.; Holoshitz, J. Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling. Arthritis Rheumatol. 2013, 65, 618–626.
80. Santoro, M.G. Heat shock factors and the control of the stress response. Biochem. Pharmacol. 2000, 59, 55–63.
81. Ospelt, C.; Camici, G.G.; Engler, A.; Kolling, C.; Vogetseder, A.; Gay, R.E.; Michel, B.A.; Gay, S. Smoking induces transcription of the heat shock protein system in the joints. Ann. Rheum. Dis. 2014, 73, 1423–1426.
82. Mattey, D.L.; Brownfield, A.; Dawes P.T. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. J. Rheumatol. 2009, 36, 1180–1187.
83. Abhishek, A.; Butt, S.; Gadsby, K.; Zhang, W.; Deighton, C.M. Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers. J. Clin. Rheumatol. 2010, 16, 15–18.
84. Potter, C.; Hyrich, K.L.; Tracey, A.; Lunt, M.; Plant, D.; Symmons, D.P.; Thomson, W.; Worthington, J.; Emery, P.; Morgan, A.W. et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Ann. Rheum. Dis. 2009, 68, 69–74.
85. Bobbio-Pallavicini, F.; Caporali, R.; Alpini, C.; Avalle, S.; Epis, O.M.; Klersy, C.; Montecucco, C. High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis. Ann. Rheum. Dis. 2007, 66, 302–307.
86. Braun-Moscovici, Y.; Markovits, D.; Zinder, O.; Schapira, D.; Rozin, A.; Ehrenburg, M.; Dain, L.; Hoffer, E.; Nahir, A.M.; Balbir-Gurman, A. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis. J. Rheumatol. 2006, 33, 497–500.
87. Lee, DM.; Phillips, R.; Hagan, E.M.; Chibnik, L.B.; Costenbader, K.H.; Schur, P.H. Quantifying Anti-CCP titer: Clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2009, 68, 201–208.
88. Glossop, J.R.; Dawes, P.T.; Mattey, D.L. Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology 2006, 45, 1223–1229.
89. Tollerud, D.J.; Weiss, S.T.; Leung, D.Y. Elevated soluble interleukin-2 receptors in young healthy cigarette smokers: Lack of association with atopy or airways hyperresponsiveness. Int. Arch. Allergy Immunol. 1992, 97, 25–30.
90. Tollerud, D.J.; Kurman, C.C.; Nelson, D.L.; Brown, L.M.; Maloney, E.M.; Blattner W.A. Racial variation in serum-soluble interleukin-2 receptor levels: A population-based study of healthy smokers and nonsmokers. Clin. Immunol. Immunopathol. 1994, 70, 274–279.
91. Kuliala, A.; Nissinen, R.; Kautiainen, H.; Repo, H.; Leirisalo-Repo, M. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Ann. Rheum. Dis. 2006, 65, 26–29.
92. Park, S.J.; Shin, J.I. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug: Comments on the article by Söderlin et al. Scand. J. Rheumatol. 2012, 41, 411–412.
93. Metsios, G.S.; Stavropoulos-Kalinoglou, A.; Nevill, A.M.; Douglas, K.M.; Koutedakis, Y.; Kitas, G.D. Smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2000, 67, 70–73.
94. Westhoff, G.; Rau, R.; Zink, A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 2008, 47, 849–854.
95. Stamp, L.K.; O’Donnell, J.L.; Chapman, P.T.; Zhang, M.; Frampton, C.; James, J.; Barclay, M.L. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Arthritis Rheumatol. 2009, 60, 2248–2256.
96. Wolbink, GJ.; Vis, M.; Lems, W.; Voskuyl, A.E.; de Groot, E.; Nurmohamed, M.T.; Stapel, S.; Tak, P.P.; Aarden, L.; Dijkmans, B. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. Arthritis Rheumatol. 2006, 54, 711–715.
97. Bendtzen, K.; Geborek, P.; Svenson, M.; Larsson, L.; Kapetanovic, M.C.; Saxne, T. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with tumor necrosis factor alpha inhibitor infliximab. Arthritis Rheumatol. 2006, 54, 3782–3789.
98. Turesson, C.; Jacobsson, L.T. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand. J. Rheumatol. 2004, 33, 65–72.
99. Turesson, C.; Jacobsson, L.; Bergström, U. Extra-articular rheumatoid arthritis: Prevalence and mortality. Rheumatology (Oxford) 1999, 38, 668–674.
100. Turesson, C.; O’Fallon, W.M.; Crowson, C.S.; Gabriel, S.E.; Matteson, E.L. Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years. Ann. Rheum. Dis. 2003, 62, 722–727.
101. Kim, S.K.; Park, S.H.; Shin, I.H.; Choe, J.Y. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J. Rheumatol. 2008, 35, 995–1001.
102. Moura, M.C.; Zakszewski, P.T.; Silva, M.B.; Skare, T.L. Epidemiological profile of patients with extra-articular manifestations of rheumatoid arthritis from the city of Curitiba, south of Brazil. Rev. Bras. Reumatol. 2012, 52, 679–694.
103. Nyhäll-Wåhlin, B.M.; Petersson, I.F.; Nilsson, J.A.; Jacobsson, L.T.; Turesson, C.; BARFOT Study Group. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis. Rheumatology (Oxford) 2009, 48, 416–420.
104. De Rooy, D.P.; van Nies, J.A.; Kapetanovic, M.C.; Kristjansdottir, H.; Andersson, M.L.; Forslind, K.; van der Heijde, D.M.; Gregersen, P.K.; Lindqvist, E.; Huizinga, T.W. et al. Smoking as a risk factor for the radiological severity of rheumatoid arthritis: A study on six cohorts. Ann. Rheum. Dis. 2014, 73, 1384–1387.
105. Saevarsdottir, S.; Rezaei, H.; Geborek, P.; Petersson, I.; Ernestam, S.; Albertsson, K.; Forslind, K.; van Vollenhoven, R.F.; for the SWEFOT Study Group. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: Results from the SWEFOT trial. Ann. Rheum. Dis. 2014, doi:10.1136/annrheumdis-2013-204601.